Skip to:

NEWS

Aug 28 | Summer’s harvest now in the Citations Database


We just increased the size of our Citations Database with more than 100 recently published scientific papers.

...read more

Aug 22 | Yet another successful cancer vaccine trial


In a Nature Letters article published in July 2017, a group from the Dana-Farber Cancer Institute led by Catherine Wu reported an exciting proof-of-principle study showing that a personal neoantigen vaccine is safe, strongly immunogenic, and capable of inducing tumor-reactive T cells.

...read more

"I cannot compare the new mouse IL-10 system to the old system, as I never used it, but I was able to obtain very nice results with the new system. The spots show up clearly and there is no variation in the background color of the membranes (this is a problem I have had with other companies' kits, and am told it has to do with uneven pre-coating). I have used other Mabtech products in the past (human and mouse IFN-gamma, IL-2, and TNF-alpha) and will continue to use them. "
Julie Roda, PhD
NGM Biopharmaceuticals Inc
USA
"Mabtech service is highly customer-friendly and efficient. We have been using Mabtech ELISA kits for the past eight years with full satisfaction. Furthermore, I find Mabtech products the best for even developing my in-house ELISA."
Laksiri Gomes
Centre for Dengue Research
University of Sri Jayawardenepura
Sri Lanka
"Amazing! Your delivery time system is really efficient. We are really impressed about it."
Susana Gargallo
ARACLON BIOTECH, S.L.,
Spain